Key result
Levosimendan was successfully and safely used in 2 critically ill term newborns with acute heart failure and pulmonary hypertension.
Why the study?
Does levosimendan improve outcomes in critically ill term newborns with acute heart failure and pulmonary hypertension?
Population
2 critically ill term newborns with acute heart failure and pulmonary hypertension in the absence of any…
Design
Case_report
Authors
Loading...
Should not yet change practice; hypothesis-generating for levosimendan in term neonates with acute heart failure and pulmonary hypertension.
Case Report (n=2)
Does levosimendan improve outcomes in critically ill term newborns with acute heart failure and pulmonary hypertension?
Levosimendan may be a safe and effective treatment option for acute heart failure and pulmonary hypertension in term neonates without structural heart disease.
Carolis et al. (2011) conducted a case report in Acute heart failure and pulmonary hypertension (n=2). Levosimendan was evaluated on Successful and safe use. Levosimendan was successfully and safely used in 2 critically ill term newborns with acute heart failure and pulmonary hypertension.